Diagnostic Performance and Safety of Ultrasound‐Guided Core Needle Biopsy for Diagnosing Lymphoma: A Systematic Review and Meta‐Analysis
2025

Ultrasound-Guided Core Needle Biopsy for Diagnosing Lymphoma

Sample size: 13 publication Evidence: high

Author Information

Author(s): Kwon Yongmin, Lee Min Kyoung

Primary Institution: Department of Radiology, Yeouido St. Mary's Hospital, College of Medicine The Catholic University of Korea

Hypothesis

What is the diagnostic accuracy and safety of ultrasound-guided core needle biopsy in patients with lymphoma?

Conclusion

Ultrasound-guided core needle biopsy shows high diagnostic accuracy and low complication rates in lymphoma patients.

Supporting Evidence

  • The pooled sensitivity of ultrasound-guided core needle biopsy was 94%.
  • The specificity was 100%.
  • The pooled complication rate was 1%, mostly self-limiting.
  • US-guided CNB is a viable alternative to surgical excisional biopsy for lymphoma diagnosis.
  • Most studies showed high diagnostic accuracy for US-guided CNB.

Takeaway

Doctors can use a special needle guided by ultrasound to take samples from lymphoma patients, and it works really well with few problems.

Methodology

A systematic review and meta-analysis were conducted using data from various studies on ultrasound-guided core needle biopsy in lymphoma patients.

Potential Biases

Some studies had unclear risks of bias in patient selection and flow timing.

Limitations

Limited direct comparisons with surgical excisional biopsy and insufficient data on specimen number and size.

Participant Demographics

Included studies had participants ranging from 24 to 735, with male proportions varying from 8% to 64% and mean ages from 38.0 to 61.1 years.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI: 89%–96%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/cam4.70414

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication